Top Michelin Chefs Steer a 10-Star Epicurean Adventure Through East Asia at the Third Edition of MGM x RR1HK Culinary Masters Macau

Top Michelin Chefs Steer a 10-Star Epicurean Adventure Through East Asia at the Third Edition of MGM x RR1HK Culinary Masters Macau

Exemplifying Gastronomic Excellence in a Harmonious Blend to Celebrate Macau as the Creative City of Gastronomy and the Culture City of East Asia MACAU, June 10, 2025 /PRNewswire/ -- MGM x RR1HK Culinary Masters Macau 2025, the highly anticipated...

Wingderm® Strengthens Presence in Asia at IMCAS Asia 2025

Wingderm® Strengthens Presence in Asia at IMCAS Asia 2025

BEIJING, June 10, 2025 /PRNewswire/ -- From June 6 to 8, 2025, IMCAS Asia was successfully held in Bangkok, Thailand. As one of the world's leading medical aesthetic events, IMCAS Asia brought together the latest developments and trends in the Asian...

Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach

Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025. Encouraging clinical data showed that patients receiving 60 mg QD Rentosertib experienced...

Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting

Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting

SUZHOU, China, June 3, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that multiple clinical data updates for anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 were presented as posters at the 2025 Annual Meeting of...

Mega Matrix Inc. Presented FlexTV Weekly Highlights from May 19 to 23, 2025, Featuring Desire Maze, Ethical Dilemmas and Breakthrough Manual

Mega Matrix Inc. Presented FlexTV Weekly Highlights from May 19 to 23, 2025, Featuring Desire Maze, Ethical Dilemmas and Breakthrough Manual

SINGAPORE, May 28, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU) launched seven English mini-series on its short drama platform FlexTV between May 19 and May 23, 2025, each illuminating life's myriad vicissitudes. Through tales of...

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTnm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTnm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting

TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of...

Dot Inc. Presented 'Inclusive AI' Innovations at Microsoft Build 2025

Dot Inc. Presented 'Inclusive AI' Innovations at Microsoft Build 2025

Joining Microsoft's Copilot ecosystem, unveiling AI accessibility on the stage 'Dot Vista' demo shows tactile conversion of visual content by leveraging Windows AI APIs and Copilot+ PCs PowerPoint reimagined as a tactile interface for the visually...

Alphamab Oncology Presented Preclinical Data on Two Novel Bispecific ADCs at the 2025 AACR Annual Meeting

Alphamab Oncology Presented Preclinical Data on Two Novel Bispecific ADCs at the 2025 AACR Annual Meeting

SUZHOU, China, April 30, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American...

ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting

ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting

SUZHOU, China, April 28, 2025 /PRNewswire/ -- From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster...

Mega Matrix Inc. Presented FlexTV New Releases (March 31 - April 4): Springtime Sweet Romance - Contract Marriages, Reunited Lovers, and Family Revelations

Mega Matrix Inc. Presented FlexTV New Releases (March 31 - April 4): Springtime Sweet Romance - Contract Marriages, Reunited Lovers, and Family Revelations

SINGAPORE, April 10, 2025 /PRNewswire/ -- From March 31 to April 4, 2025, FlexTV, the global short-drama platform under Mega Matrix Inc. (NYSE American: MPU), released five new English-language dramas. From sweet twists in contract marriages to...

  • 1
  • 2
  • 3
  • menu
    menu